1. Home
  2. BFS vs CGEM Comparison

BFS vs CGEM Comparison

Compare BFS & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFS

Saul Centers Inc.

HOLD

Current Price

$31.94

Market Cap

759.2M

Sector

Real Estate

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.04

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
CGEM
Founded
1993
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
759.2M
671.7M
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
BFS
CGEM
Price
$31.94
$10.04
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.00
AVG Volume (30 Days)
75.9K
1.6M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
7.39%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$282,618,000.00
N/A
Revenue This Year
$8.14
N/A
Revenue Next Year
$5.75
N/A
P/E Ratio
$27.99
N/A
Revenue Growth
5.61
N/A
52 Week Low
$29.16
$5.68
52 Week High
$40.47
$13.33

Technical Indicators

Market Signals
Indicator
BFS
CGEM
Relative Strength Index (RSI) 60.41 47.45
Support Level $31.42 $9.48
Resistance Level $32.45 $13.10
Average True Range (ATR) 0.59 0.98
MACD 0.16 -0.31
Stochastic Oscillator 80.99 13.26

Price Performance

Historical Comparison
BFS
CGEM

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: